Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Calcitonin
Therapeutic Area : Endocrinology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Leucadia Pharmaceuticals Launches Calcitonin Salmon Injection
Details : The Calcitonin Salmon injection is therapeutically equivalent or generic of MIACALCIN® and is indicated for the early treatment of hypercalcemic emergencies when a rapid decrease in serum calcium is required.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 17, 2021
Lead Product(s) : Calcitonin
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable